Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-060147
Filing Date
2014-10-08
Accepted
2014-10-08 16:05:27
Documents
1
Period of Report
2014-10-07

Document Format Files

Seq Description Document Type Size
1 form470708_20141008040416-.html 4  
1 form470708_20141008040416-.xml 4 5480
  Complete submission text file 0001144204-14-060147.txt   6932
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 425 METRO PLACE N., SUITE 300 DUBLIN OH 43017
Business Address
Tulip Thomas H. (Reporting) CIK: 0001528192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 141147941